Drug Price Controls in the US: Same, Same but Different?

In 2017, when India introduced price controls on coronary stents, the United States Trade Representative (USTR) had requested the Prime Minister to not extend price controls to additional medical devices. When India refused to heed to the request, amongst other things, the National Trade Estimate Report on Foreign Trade Barriers reported the measure of price capping to be without a sense of differentiation between newer and older products ( here , p. 235), India’s eligibility for US’ Generalized System of Preferences ( GSP ) was reviewed and the policy measure was flagged out to be “very troubling”. The coronary stent episode was just …

Read the source article at SpicyIP
2021-10-24 08:28:21